TR199600455A2 - Lesopitron dihidroklorid'in yeni polimorflari ve hidratlanmis bicimleri, hazirlama prosesleri ve bunu iceren bilesimler. - Google Patents

Lesopitron dihidroklorid'in yeni polimorflari ve hidratlanmis bicimleri, hazirlama prosesleri ve bunu iceren bilesimler.

Info

Publication number
TR199600455A2
TR199600455A2 TR96/00455A TR9600455A TR199600455A2 TR 199600455 A2 TR199600455 A2 TR 199600455A2 TR 96/00455 A TR96/00455 A TR 96/00455A TR 9600455 A TR9600455 A TR 9600455A TR 199600455 A2 TR199600455 A2 TR 199600455A2
Authority
TR
Turkey
Prior art keywords
compositions containing
preparation processes
hydrated forms
new polymorphs
lesopitron dihydrochloride
Prior art date
Application number
TR96/00455A
Other languages
English (en)
Turkish (tr)
Inventor
Pilar Lupon Proses
Jaime Tomas Navarro
Salvador Puig Torres
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of TR199600455A2 publication Critical patent/TR199600455A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR96/00455A 1995-05-31 1996-05-31 Lesopitron dihidroklorid'in yeni polimorflari ve hidratlanmis bicimleri, hazirlama prosesleri ve bunu iceren bilesimler. TR199600455A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.

Publications (1)

Publication Number Publication Date
TR199600455A2 true TR199600455A2 (tr) 1996-12-21

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
TR96/00455A TR199600455A2 (tr) 1995-05-31 1996-05-31 Lesopitron dihidroklorid'in yeni polimorflari ve hidratlanmis bicimleri, hazirlama prosesleri ve bunu iceren bilesimler.

Country Status (29)

Country Link
US (1) US5872125A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0771798A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH10503532A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1076020C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR003952A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU699210B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG62966B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2196425A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO4700461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ24797A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE9700067A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2099031B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GE (1) GEP20002241B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP9700284A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL118494A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN186820B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS4420A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA23883A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9700792A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO310073B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ308110A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL318280A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2178789C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK12697A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199600455A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY24241A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1996038439A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU32396A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA964139B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206109B (en) * 1987-10-26 1992-08-28 Pfizer Process for producing heterocyclic carbonylpropyl pyrimidinyl piperazine derivatives and pharmaceutical compositions comprising same
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
JP3001281B2 (ja) * 1991-03-06 2000-01-24 日本碍子株式会社 ハニカムモノリスヒータ
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
AR003952A1 (es) 1998-09-30
GEP20002241B (en) 2000-09-25
AU5765096A (en) 1996-12-18
NZ308110A (en) 1997-08-22
SK12697A3 (en) 1997-07-09
JPH10503532A (ja) 1998-03-31
HUP9700284A3 (en) 1998-01-28
CN1158128A (zh) 1997-08-27
BG101176A (en) 1997-08-29
YU32396A (sh) 1999-07-28
CO4700461A1 (es) 1998-12-29
NO310073B1 (no) 2001-05-14
MA23883A1 (fr) 1996-12-31
IL118494A0 (en) 1996-09-12
UY24241A1 (es) 1996-06-14
CZ24797A3 (en) 1997-05-14
IS4420A (is) 1997-01-29
US5872125A (en) 1999-02-16
EP0771798A1 (en) 1997-05-07
MX9700792A (es) 1997-05-31
HUP9700284A2 (en) 1997-11-28
EE9700067A (et) 1997-10-15
ES2099031B1 (es) 1997-12-01
AU699210B2 (en) 1998-11-26
CN1076020C (zh) 2001-12-12
HU9700284D0 (en) 1997-04-28
IN186820B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2001-11-17
PL318280A1 (en) 1997-06-09
NO970392L (no) 1997-04-01
BG62966B1 (bg) 2000-12-29
ZA964139B (en) 1997-02-06
ES2099031A1 (es) 1997-05-01
RU2178789C2 (ru) 2002-01-27
WO1996038439A1 (es) 1996-12-05
NO970392D0 (no) 1997-01-29
CA2196425A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
TR199901653T2 (xx) Fitalazinonlar.
DZ2036A1 (fr) N-(indole-2-carbonyl)-beta-alaninamides substituéset leurs dérivés, servant d'agents antidiabétiques.
DE69601765D1 (de) Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
TR199501229A2 (tr) Yeni bilesim.
HU9503194D0 (en) Novel sunsscreens, photoprotective cosmetic compositions containing them and uses thereof
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
HU9603237D0 (en) Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane
IT1295645B1 (it) Apparecchio per l'elettroemanazione di principi attivi.
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
DE59504401D1 (de) Johanniskrautextrakte
FR2733149B1 (fr) Nouvelles compositions cosmetiques amincissantes
FR2732215B1 (fr) Nouvelles compositions cosmetiques depigmentantes
TR200401775T4 (tr) 3-Amino-1-Fenil-1H[1,2,4] triazol'ün dallanmış değiştirilmiş yeni amino türevleri, bunların imali için metot ve bunları içeren farmosötik (eczacılık) bileşimleri
ZA962847B (en) Treatment of traveller's diarrhea.
FR2716374B1 (fr) Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
TR199601012A2 (tr) Sampuan terkibi.
Green Traditional norms of masculinity
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
TR199600455A2 (tr) Lesopitron dihidroklorid'in yeni polimorflari ve hidratlanmis bicimleri, hazirlama prosesleri ve bunu iceren bilesimler.
FR2729856B1 (fr) Composition cosmetique amincissante
IT1281757B1 (it) Impastatrice, in particolare per l'edilizia
EP0866709A4 (en) 1,2,4-benzotriazine oxides formulations
DE69600766D1 (de) Cyclohexyloxycarbonylacetohydrazide, und ihre Verwendung für die Herstellung von 1H-1,2,4-Triazolen
FR2735023B1 (fr) Nouvelles compositions cosmetiques amincissantes
NO985550D0 (no) FremgangsmÕte for fremstilling av 2,2'-(1-metyl-1,2-etandiyliden)bis(hydrazinkarboksimidamid)